The Global Dermatological Drug Market is accounted for USD 25.65 billion in 2016 growing at a CAGR of 4.5% during the forecast period of 2017 to 2024. The upcoming market reports contain data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
- Advertising -
Global Dermatology Drugs Market, By Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer and Others); Prescription mode (Prescription Based Drugs, Over Counter Drugs); Drug Classification (Corticosteroids, Astringents, Anti-Inflammatory & Antipruritic Drugs, Anti-Infective/Antibacterial Drugs, Antifungal Drugs), Route Of Administration (Topical, Oral, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); End User (Hospitals, Speciality Clinics, Cosmetic Centres); Geography (North America, Europe, Asia-Pacific, South America, Middle East, Africa).
Dermatological drugs are used in the management and treatment of diseases related to skin, nail, hair, and genital membranes.
Major Market Drivers and Restraints:
- Growing number of skin diseases across all age-groups
- Rising expenditure on personal care
- Stringent regulations for dermatology drugs approval
On the basis of diseases, the global dermatology drugs market is segmented into acne, dermatitis, psoriasis, skin cancer and others.
On the basis of prescription mode, the global dermatology drugs market is segmented into prescription based drugs and over the counter drugs.
- Advertising -
On the basis of drug classification, the global dermatology drugs market is segmented into corticosteroids, astringents, anti-inflammatory and antipruritic drugs, anti-infective/antibacterial drugs and antifungal drugs.
On the basis of route of administration of drugs, the segmentation of dermatology drugs market is topical, oral and parenteral administration.
On the basis of distribution channels, global dermatology drugs market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.
On the basis of end users, global dermatology drugs market is segmented into hospitals, speciality clinics and cosmetic centres.
Based on geography, the market is segmented into five geographical regions:
- North America
- South America
- Middle East and Africa(MEA)
The Global Dermatology Drug Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market.
Global Dermatology Drug Market is dominated by
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Pfizer Inc., Sanofi
- GlaxoSmithKline plc
- Amgen Limited
- Eli Lilly and Company
- AbbVie Inc
- Johnson & Johnson Services Limited
- Galderma S. A, LEO Pharma A/S, Merck & Co., Inc
- Valeant, and Bristol-Myers Squibb Company
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models.
market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: